Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)
Clinical trial NCT03809377 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03809377
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-05-09
- Primary completion
- 2026-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.